The Recall Desk
ModerateFDA (Drugs)·D-0043-2025·Announced 2024-11-20

Lanthanum Carbonate 1000mg Chewable Tablets Recalled for Broken and Crushed Tablets

Cipla USA is recalling Lanthanum Carbonate Chewable Tablets, 1000mg due to complaints of crushed and broken tablets. The recall affects 1,875 boxes distributed nationwide.

What this means for you

Minor labeling or packaging issue, or a voluntary precautionary recall. Risk of harm is low but real — follow the manufacturer's instructions.

Our severity reasoning: FDA Class II recall based on failed tablet specifications (crushed and broken tablets). The source documents no associated illnesses, injuries, or hospitalizations. The hazard is a physical defect affecting product integrity rather than chemical or biological safety.

Plain-English summary

Cipla USA, Inc. is recalling Lanthanum Carbonate Chewable Tablets, 1000mg (10-count bottles) due to failed tablet specifications. The company received complaints that tablets in affected lots are crushed or broken.

The recalled product (NDC 69097-0936-98, Lot #NB240316, Exp 12/31/25) was distributed nationwide. The recall affects approximately 1,875 boxes.

The recalled product

Product
Lanthanum Carbonate Chewable Tablets, 1000mg, 10-count bottle, Rx only, Manufactured for Cipla USA, NDC 69097-0936-98
Manufacturer
Cipla USA, Inc.
Category
Drug — Prescription Medication
Hazard
Affected units
1,875

Is your product affected?

Check your packaging against the codes below. If any of them match, the product is part of this recall.

Lot numbers (2)

  • Lot # NB240316
  • Exp 12/31/25

Distribution

Distributed nationwide across the United States.

Part of a larger recall action

This product is one of 2 recalled by Cipla USA, Inc. under a single FDA (Drugs) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.

See all 2 products in this recall →

Related recalls

Same manufacturer · Cipla USA, Inc.

See all →

Same hazard · broken tablets

See all →